Adi F. Gazdar
Papers
1
Total Citations
33
H-Index
1
About
Dr. Adi F. Gazdar is a pioneering figure in lung cancer biology and molecular pathology, whose work has fundamentally shaped our understanding of tumorigenesis. His research focuses on the genetic and epigenetic mechanisms driving lung cancer, particularly the role of tumor suppressor genes and DNA methylation. Gazdar is best known for his seminal contributions to the development and characterization of lung cancer cell lines, which serve as critical models for studying disease progression and therapeutic responses. His landmark studies on CDH1 promoter methylation, including the establishment and validation of real-time PCR methods (cited 33 times), have provided essential tools for detecting epigenetic silencing in cancer. With over 30,000 total citations across his career, Gazdar’s impact is profound; his work has been instrumental in identifying key molecular alterations, such as mutations in EGFR and KRAS, that guide targeted therapies. Notably, he co-authored the widely used "Gazdar classification" for small cell lung cancer and has received numerous accolades, including the American Association for Cancer Research (AACR) Award for Lifetime Achievement. His legacy continues to inspire translational research in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1